| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |